What a normal blood test result actually means

You went in with a symptom and came out with a page of numbers and a sentence: “everything looks normal.” The sentence is accurate. It is also answering a narrower question than the one you asked.

This article explains what a reference range is, how it is built, and why a result inside one does not settle the question of how you feel.

What does a “normal” blood test result actually mean?

It means your result sat inside the range that covers most of a healthy reference group for that test, at that laboratory, on that analyser. It is a statement about a population. It is not a measurement of where your own body usually sits, and it does not describe how you feel.

How is a reference range worked out?

A laboratory tests a group of people it treats as healthy and plots the results. It cuts off the lowest 2.5% and the highest 2.5%. The middle 95% becomes the reference range. That range describes a group. Convention decides where the edges fall.

A review in the Journal of the American Board of Family Medicine sets out the method plainly. Around 120 healthy people are tested, “the lowest 2.5% and highest 2.5% of the values are excluded and the values comprising the central 95% are adopted as the reference range” (Zaman, 2025).

So the boundary is a percentile. It is not a line where health stops.

Why do healthy people get flagged as abnormal?

Because the range was built to leave 5% of healthy people outside it. That is arithmetic rather than illness. About 1 in 20 healthy people will fall outside the range on any single test. The more tests you run, the more likely a flag becomes.

The same review does the sum for a panel. “The probability of no abnormal test result in a healthy subject, in a panel of 20 tests is (0.95)^20 = 0.358. Thus, 64.2% of ‘normal’ patients will have at least one ‘abnormal’ test result in a panel of 20 tests” (Zaman, 2025).

Pathology Tests Explained, the Australian public resource for people reading their own reports, says the same thing in plainer words. A flagged result “does not indicate that you are unwell and may not mean anything in your personal situation” (Pathology Tests Explained).

Why do two laboratories give different ranges for the same test?

Different laboratories use different analysers, different methods and different reference groups. So the printed range for the same test can shift depending on who ran it. This is why you should read the range on your own report rather than one you found online, and why comparing a result against a range from another lab can mislead you.

The gap is bigger than most people expect. Australasian work on harmonising ranges found that for the majority of common chemistry tests, the variation between laboratories’ reference intervals was greater than the variation in the results themselves (Tate et al., Clin Chem Lab Med, 2018). Eighteen analytes now have harmonised intervals endorsed by the Royal College of Pathologists of Australasia.

Pathology Tests Explained puts the practical version bluntly: “reference intervals can differ between laboratories for the same tests.”

Is a reference range the same as a healthy target?

No. For some tests the number that matters is a clinical decision limit, which is set from outcome data rather than from a healthy group. HbA1c and cholesterol work this way. A reference range tells you who is typical. A decision limit tells you where risk changes.

The International Federation of Clinical Chemistry review on this makes the distinction explicit. Reference intervals “describe the typical distribution of results seen in a healthy reference population”, while clinical decision limits are “associated with a significantly higher risk of adverse clinical outcomes” (Ozarda et al., Crit Rev Clin Lab Sci, 2018).

A reference range and a decision limit answer different questions. Your report can print both in the same column.

Can you feel unwell with results inside the range?

Yes, and there are ordinary clinical reasons why. A range can be wide enough that your result sits inside it while sitting a long way from where your own body normally runs. Some markers are also pushed around by other things happening in the body at the time.

Ferritin is a worked example. Writing in the Medical Journal of Australia, Zhang and colleagues note that ferritin “may be falsely normal or elevated in iron deficient individuals when there is concurrent inflammation, obesity, steatotic liver disease, malignancy or other chronic disease”. In that setting, a ferritin under 70 micrograms per litre “may suggest iron deficiency”, even though the printed lower limit sits at 30 (Zhang et al., MJA, 2024).

The point is not that the range is wrong. The range is doing its job. A number still has to be read next to the person it came from.

Why “everything looks normal” can feel like a dead end

The sentence is true and it is worth having. It says the tests that were done did not return a result outside the range, which rules some things out. What it cannot do is explain a symptom. It is reporting on a set of measurements, and you came in with an experience.

So the frustration comes from a gap. You arrived with a symptom and left with a statistic. Pathology answers the question it was asked, and it answers it well. The question you brought was a different one.

Pathology Tests Explained says results “need to be considered in the context of your whole clinical history including any other investigations you have had”. That context is a conversation. It is not something a printed range can supply.

What does a practitioner do with a borderline result?

They read it next to you. That means your history, your symptoms, your other results, and anything that could move the number. A borderline result is often repeated after a set interval, because a single reading and a trend are different things.

Sometimes the correct next step is to wait and re-check. The Royal Australian College of General Practitioners describes watchful waiting as “monitoring the patient’s condition, but not providing treatment immediately”, with symptoms to look out for and an agreed time to come back (RACGP, Over-testing, 2023). The same document talks about “the advantages of not rushing to a diagnosis”.

Waiting is itself a decision. It has a review date attached to it.

Would more testing give you a clearer answer?

Often it produces a longer list instead of a clearer one. Every extra test raises the chance of a flag that means nothing, and wider testing also finds things that were never going to cause trouble. Both create work, cost and worry that the finding did not warrant.

Australian general practice guidance is direct about this. The RACGP defines over-testing as testing where “the result of the test would not alter how you manage the patient or their symptoms, or change their health outcomes”, or where “there are more potential harms than benefits from taking the test”. It names three harms: overdiagnosis from picking up an “incidentaloma”, which “could lead to treatment that is unnecessary, expensive and potentially dangerous”; false-positive results, which cause “unnecessary further testing or treatments”; and false-negative results, “which provide inappropriate reassurance that can delay correct diagnosis and appropriate treatments” (RACGP, 2023).

Imaging shows the scale of the incidental-finding problem. A systematic review and meta-analysis in the BMJ looked at brain and body MRI in apparently asymptomatic adults. Pooled prevalence of potentially serious incidental findings was 3.9%. Once findings of uncertain seriousness were included, it rose to 12.8% (Gibson et al., BMJ, 2018;363:k4577).

Some screening is recommended against for this reason. Choosing Wisely Australia carries an RCPA recommendation not to perform population-based screening for vitamin D deficiency (Choosing Wisely Australia).

The RACGP states the rule plainly: “If the results will not change how your patient is managed, then do not order the test.”

What a normal result cannot tell you

Restraint has a failure mode too. A test that is never ordered cannot find anything, and the RACGP names false negatives as a harm precisely because inappropriate reassurance delays correct diagnosis. Judgement can be wrong in both directions, including ours. Restraint in testing is a clinical position rather than a guarantee, and it is worth holding it that way.

There is a second limit. Without a baseline from a period when you felt well, nobody can say where your own numbers usually sit. Most people do not have one. That makes a first set of results a starting point rather than an answer.

And there is a third. Sometimes the results are normal, the reading is careful, and the bloods still hold no explanation. The cause may sit somewhere pathology does not reach, or it may need time to show itself. That happens, and it is worth saying out loud rather than covering it with another panel.

Nothing in this article tells you what your own result means. Only a practitioner who has your history in front of them can do that.

How BioLyfe approaches a result you are unsure about

You bring the concern and any results you already have. You speak with one of our practitioners in a live consultation, by video or phone. Before you book, you are told what the consultation covers, what would be measured, and what that comes to as a total. Any testing is chosen for the question in front of you.

If deemed medically appropriate, the outcome may be advice, a referral to another doctor, monitoring, a change to how you live, further investigation, or no treatment at all. With your consent, we work alongside your GP and any other practitioner you already see, and we tell you what gets shared with them.

A next step, if you want one

Find the old reports. Most Australian laboratories will send you copies, and your GP holds them too. Two or three sets of the same test over a few years say more than one set does, because they show a direction. This is the idea behind a personal baseline in longevity care: your own results over time say more than a single comparison with a population. That costs nothing and it makes any appointment more useful, whether that is with us or with your own GP.

To explore a review of your health and results, our areas of care explain what an assessment can cover. You can also ask us a question first.

Sources

• Zaman A. Interpreting Normal Values and Reference Ranges for Laboratory Tests. Journal of the American Board of Family Medicine, Vol 38, No 1, 2025
• Pathology Tests Explained (Australia), Reference intervals explained
• Tate JR, Koerbin G, Sikaris K, et al. An update report on the harmonization of adult reference intervals in Australasia. Clinical Chemistry and Laboratory Medicine, 2018
• Ozarda Y, Sikaris K, Streichert T, Macri J. Distinguishing reference intervals and clinical decision limits. Critical Reviews in Clinical Laboratory Sciences, Vol 55, No 6, 2018
• Zhang GD, Johnstone D, Leahy MF, Olynyk JK. Updating the diagnosis and management of iron deficiency in the era of routine ferritin testing of blood donors. Medical Journal of Australia, Vol 221, No 7, 2024
• Royal Australian College of General Practitioners, Over-testing, Managing uncertainty series, December 2023
• Gibson LM, Paul L, Chappell FM, et al. Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis. BMJ 2018;363:k4577
• Choosing Wisely Australia, Do not perform population based screening for Vitamin D deficiency, Royal College of Pathologists of Australasia